Certified genetic counselor Kate Wilson discusses both clinical care and insurance billing and coverage issues surrounding gene panel testing. Numerous studies have shown higher positive rates when testing with larger panels. Why do higher positive rates not necessarily lead to better insurance coverage? What will it take to get data showing a reduction in morbidity and mortality and demonstrating utility for medical management? Kate also provides insight into the complexities of billing for panels and the downsides of low-self pay pricing within an insurance-based healthcare system.
Do you have questions or topics you’d like a genetic counselor to discuss on a future episode ?Leave us a short voice message here! We may use your message on a future show.
Related Articles
Robson M, Domchek S. “Broad Application of Multigene Panel Testing for Breast Cancer Susceptibility—Pandora’s Box Is Opening Wider.” JAMA Oncol. October 3, 2019.
Ray, Turna. “Concert Genetics Launches Software to Limit Coding Variability in Genetic Testing.”Genome Web. September 6, 2019.
Follow Kate on Twitter
Connect with Kate on LinkedIn